Squamous cell carcinoma of the head and neck-The role of diffusion and perfusion imaging in tumor recurrence and follow-up

Reports of Practical Oncology and Radiotherapy

Volumn 16, Issue 6, 2011, Pages 207-212

  Trojanowska, Agnieszka ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Diffusion weighted imaging; Functional imaging; Perfusion imaging; Recurrence; Squamous cell carcinoma

Indexed keywords

CANCER DIAGNOSIS; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; REVIEW; SQUAMOUS CELL CARCINOMA;

EID: 82755197955     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rpor.2011.06.006     Document Type: Review

References (24)

1. Lemort M., Canizares Ch., Kampouridis S. Advances in imaging head and neck tumours. Curr Opin Oncol 2006, 18:234-239.
2. Shah G.V., Wesolovski J., Ansari S.A., et al. New directions in head and neck imaging. J Surg Oncol 2008, 97:644-648.
3. Weber A.L., Romo L., Hashmi S. Malignant tumors of the oral cavity and oropharynx: clinical, pathologic and radiologic evaluation. Neuroimag Clin N Am 2003, 13:443-464.
4. Wippold F.J. Head and neck imaging: the role of CT and MRI. J Magn Reson Imaging 2007, 25:453-465.
5. Vandecaveye V., De Keyzer F., Nuyts S., et al. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 2007, 67:960-971.
6. Yousem D.M. Dashed hopes for MR imaging of the head and neck: the power of the needle. Radiology 1992, 184:25-26.
7. Laubenbacher C., Saumweber D., Wagner-Manslau C. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 1992, 36:1747-1757.
8. Trojanowska A., Trojanowski P., Bisdas S., et al. Squamous cell cancer of hypopharynx and larynx-evaluation of metastatic nodal disease based on coputed tomography perfusion studies. Eur J Radiol 2011, Feb 14 [Epub ahead of print] PMID: 21324623.
9. Hermans R. Vandecaveye V: diffusion-weighted MRI in head and neck cancer. Cancer Imaging 2007, 7:126-127.
10. Wang J., Takashima S., Takayama F., et al. Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology 2001, 220:621-630.
11. Mancuso A. The " third-best" strategy for treating head and neck cancer. AJNR Am J Neuroradiol 1999, 20:1191-1192.
12. Trojanowska A., Grzycka-Kowalczyk L., Trojanowski P., et al. Computed tomography perfusion examination is helpful in evaluating the extent of oropharyngeal and oral cavity cancer. Pol Przegl Radiol 2011, 76(1):14-19.
13. Lui W., Tang E.R., Allmendinger A.M., et al. Evaluation of CT perfusion in the setting of cerebral ischemia: patterns and pitfalls. AJNR Am J Neuroradiol 2010, 31(9):1552-1563. October 1.
14. Faggioni L., Neri E., Cerri F., et al. 64-row MDCT perfusion of head and neck squamous cell carcinoma: technical feasibility and quantitative analysis of perfusion parameters. Eur Radiol 2010, 10.1007/s00330-010-1898-0.
15. Gandhi D., Hoeffner E.G., Carlos R.C., et al. Computed tomography perfusion of squamous cell carcinoma of the upper aerodigestive tract: initial results. J Comput Assist Tomogr 2003, 27:687-693.
16. Gandhi D., Chepeha D.B., Miller T., et al. Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy. AJNR Am J Neuroradiol 2006, 27(1):101-106.
17. Bisdas S., Baghi M., Smolarz A., et al. Quantitative measurements of perfusion and permeability of oropharyngeal and oral cavity cancer, recurrent disease, and associated lymph nodes using firstpass contrast-enhanced computed tomography studies. Invest Radiol 2007, 42:172-179.
18. Surlan-Popovic K., Bisdas S., Rumboldt Z., et al. Changes in perfusion CT of advanced squamous cell carcinoma of the head and neck treated during the course of concomitant chemoradiotherapy. Am J Neuroradiol 2010, 31:570-575.
19. Hermans R. Diffusion-weighted MRI in head and neck cancer. Curr Opin Otolaryngol Head Neck Surg 2010, 18:72-78.
20. Abdel Razek A.A., Kandeel A.Y., Soliman N., et al. Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. Am J Neuroradiol 2007, 28:1146-1152.
21. Vandecaveye V., de Keyzer F., Nuyts S., et al. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 2007, 67:960-971.
22. Abdel Razek A.A., Soliman N.Y., Elkhamary S., et al. Role of diffusion weighted MR imaging in cervical lymphadenopathy. Eur Radiol 2006, 16:1468-1477.
23. Lebioda A., Makarewicz R., żyromska A., et al. Measurement of tumour volume by MRI to evaluate risk of pelvic nodal metastases in early cervical carcinoma patients. Rep Pract Oncol Radiother 2009, 14:146-150.
24. Sumi M., Sakihama N., Sumi T., et al. Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. Am J Neuroradiol 2003, 79:681-687.